Thomas P. Baker

1.3k total citations
27 papers, 960 citations indexed

About

Thomas P. Baker is a scholar working on Surgery, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas P. Baker has authored 27 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Rheumatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas P. Baker's work include Eosinophilic Esophagitis (9 papers), Eosinophilic Disorders and Syndromes (7 papers) and Vasculitis and related conditions (4 papers). Thomas P. Baker is often cited by papers focused on Eosinophilic Esophagitis (9 papers), Eosinophilic Disorders and Syndromes (7 papers) and Vasculitis and related conditions (4 papers). Thomas P. Baker collaborates with scholars based in United States, Canada and France. Thomas P. Baker's co-authors include Corinne Maydonovitch, Ganesh R. Veerappan, Roy K.H. Wong, Kevin C. Abbott, Fouad J. Moawad, Stephen W. Olson, M. Kay Washington, David G. Mutch, David K. Oliver and Alexander Olawaiye and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PEDIATRICS.

In The Last Decade

Thomas P. Baker

27 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P. Baker United States 14 518 435 229 131 130 27 960
Yasemin Özlük Türkiye 18 270 0.5× 95 0.2× 280 1.2× 178 1.4× 178 1.4× 118 1.0k
Maddalena Marasà United States 14 266 0.5× 125 0.3× 242 1.1× 263 2.0× 305 2.3× 28 1.5k
G. Bánfi Italy 19 119 0.2× 256 0.6× 215 0.9× 104 0.8× 292 2.2× 40 1.1k
A. Banzato Italy 20 246 0.5× 999 2.3× 82 0.4× 124 0.9× 41 0.3× 42 1.4k
Federica Maritati Italy 18 304 0.6× 643 1.5× 423 1.8× 81 0.6× 94 0.7× 38 893
Beth‐Ann Shanker United States 8 242 0.5× 860 2.0× 115 0.5× 680 5.2× 110 0.8× 16 1.3k
Michele Iudici Italy 22 139 0.3× 340 0.8× 361 1.6× 256 2.0× 106 0.8× 56 1.1k
Ingerid Nesthus Norway 14 169 0.3× 249 0.6× 61 0.3× 126 1.0× 277 2.1× 28 879
Matvey Tsivian United States 23 471 0.9× 192 0.4× 1.1k 4.8× 19 0.1× 440 3.4× 114 1.5k
G.S.C. Chiang Singapore 17 160 0.3× 136 0.3× 166 0.7× 110 0.8× 118 0.9× 41 997

Countries citing papers authored by Thomas P. Baker

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Baker more than expected).

Fields of papers citing papers by Thomas P. Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Baker. The network helps show where Thomas P. Baker may publish in the future.

Co-authorship network of co-authors of Thomas P. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Baker. A scholar is included among the top collaborators of Thomas P. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Baker. Thomas P. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guerrero, Dubert M., et al.. (2024). Association of vaccination status and severity of SARS-CoV-2 infections in hospitalized patients. Vaccine X. 18. 100473–100473. 1 indexed citations
2.
3.
McCall, A. Scott, Gautam Bhave, Vadim Pedchenko, et al.. (2018). Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. Journal of the American Society of Nephrology. 29(11). 2619–2625. 24 indexed citations
4.
Min, Steve B., et al.. (2016). Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis. Digestive Diseases and Sciences. 61(7). 1996–2001. 30 indexed citations
5.
Min, Steve B., Cade M. Nylund, Thomas P. Baker, et al.. (2016). Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis. Journal of Clinical Gastroenterology. 51(2). 127–135. 34 indexed citations
6.
Olson, Stephen W., et al.. (2015). Longitudinal plasma metanephrines preceding pheochromocytoma diagnosis: a retrospective case–control serum repository study. European Journal of Endocrinology. 174(3). 289–295. 17 indexed citations
7.
8.
Weiss, Brendan M., et al.. (2014). Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis. Journal of Clinical Oncology. 32(25). 2699–2704. 57 indexed citations
9.
Baker, Thomas P., et al.. (2014). An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma. Clinical Nephrology. 84 (2015)(8). 111–115. 4 indexed citations
10.
Olson, Stephen W., et al.. (2013). Relation between Asymptomatic Proteinase 3 Antibodies and Future Granulomatosis with Polyangiitis. Clinical Journal of the American Society of Nephrology. 8(8). 1312–1318. 25 indexed citations
11.
Thurlow, John S., Dustin J. Little, Thomas P. Baker, & Christina M. Yuan. (2013). Possible potassium chlorate nephrotoxicity associated with chronic matchstick ingestion. Clinical Kidney Journal. 6(3). 316–318. 5 indexed citations
12.
Olson, Stephen W., et al.. (2013). Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 8(10). 1702–1708. 36 indexed citations
13.
Moawad, Fouad J., et al.. (2013). Randomized Controlled Trial Comparing Aerosolized Swallowed Fluticasone to Esomeprazole for Esophageal Eosinophilia. The American Journal of Gastroenterology. 108(3). 366–372. 146 indexed citations
14.
Baker, Thomas P., et al.. (2012). Association of Prescription of Oral Sodium Polystyrene Sulfonate With Sorbitol in an Inpatient Setting With Colonic Necrosis: A Retrospective Cohort Study. American Journal of Kidney Diseases. 60(3). 409–416. 66 indexed citations
15.
Olson, Stephen W., et al.. (2011). Asymptomatic Autoantibodies Associate with Future Anti-glomerular Basement Membrane Disease. Journal of the American Society of Nephrology. 22(10). 1946–1952. 90 indexed citations
16.
Baker, Thomas P., et al.. (2010). The Common Nature of Epidemics, and Their Relation to Climate and Civilization: Also, Remarks on Contagion and Quarantine. Bulletin of Miscellaneous Information (Royal Gardens Kew). 1 indexed citations
17.
Veerappan, Ganesh R., Fouad J. Moawad, Timothy J. Duncan, et al.. (2009). 362 Non-Ulcer Dyspepsia Not Associated with Gastric or Duodenal Eosinophilia. Gastroenterology. 136(5). A–58. 2 indexed citations
18.
Veerappan, Ganesh R., Joseph L. Perry, Timothy J. Duncan, et al.. (2008). Prevalence of Eosinophilic Esophagitis in an Adult Population Undergoing Upper Endoscopy: A Prospective Study. Clinical Gastroenterology and Hepatology. 7(4). 420–426.e2. 203 indexed citations
19.
Veerappan, Ganesh R., Joseph L. Perry, Timothy J. Duncan, et al.. (2008). S1980 Prevalence of Eosinophilic Esophagitis in An Adult Population Undergoing Upper Endoscopy: A Prospective Study. Gastroenterology. 134(4). A–290. 1 indexed citations
20.
Mauskopf, Josephine, et al.. (2004). PAA10 BUDGET IMPACT ANALYSIS: COMBINATION FLUTICASONE AND SALMETEROL FOR ASTHMA. Value in Health. 7(3). 312–312. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasemin Özlük Breakdown of academic impact, for papers by Maddalena Marasà Breakdown of academic impact, for papers by G. Bánfi Breakdown of academic impact, for papers by A. Banzato Breakdown of academic impact, for papers by Federica Maritati Breakdown of academic impact, for papers by Beth‐Ann Shanker Breakdown of academic impact, for papers by Michele Iudici Breakdown of academic impact, for papers by Ingerid Nesthus Breakdown of academic impact, for papers by Matvey Tsivian Breakdown of academic impact, for papers by G.S.C. Chiang
Rankless by CCL
2026